Published
2024-06-11
Section
Articles
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Vaccination Against Coronavirus Infection In The Ferghana Region For The Period 2022-2023.
Ruzibaeva Yo.R
Fergana Medical Institute of Public Health
Mamatkulova M. T
Fergana Medical Institute of Public Health
Keywords: Vaccination, booster, pandemic, Ferghana region
Abstract
Immunization is one of the key components of primary health care, and the right to immunization is an inalienable human right. Vaccines are also crucial for preventing and suppressing outbreaks of infectious diseases. They are at the heart of global health security and will remain a vital tool in the fight against antimicrobial resistance.
References
Bray, F. Global Cancer Statistics 2018:GLOBOCAN Estimates of Incidence and
Mortality Worldwide for 36 Cancers in 185 Countries / F. Bray, J. Ferlay, I. Soerjomataram,
R.L. Siegel et al // CA Cancer J. Clin. – 2018. – V. 68. – Р. 394–424.
Comparison of risk factors for invasive squamous cell carcinoma and
adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women
with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12
epidemiological studies. Int J Cancer 2007; 120(4): 885–91.
Dugué P. A., Rebolj M., Garred P., Lynge E. Immunosuppression and risk of cervical
cancer. Expert Rev Anticancer Ther 2013; 13(1): 29–42.
Ferlay, J. Cancer incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012 / J. Ferlay, I. Soerjomataram, R. Dikshit et al // Int.
J. Cancer. – 2015. – V. 136. – Р. 359–386.
Kjaer S. K., Frederiksen K., Munk C., Iftner T. Long-term abcolut risk of cervical
intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of
persistence. J Natl Cancer Inst 2010; 102(19): 1478–88.
Rodríguez A. C., Schiffman M., Herrero R. et al. Longitudinal study of human
papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of
duration of infection. J Natl Cancer Inst 2010; 102(5): 315–24.
Rogovskaya S. I. Human papillomavirus prevalence and type-distribution, cervical
cancer screening practices and current status of vaccination implementation in Russian
Federation, the Western Countries of the former Soviet Union, Caucasus Region and Central
Asia. Vaccine 2013; 31: H 46–58.
The state of oncological care for the population of the Republic of Uzbekistan in 2020 year / edited by M. N. Tillyashaikhov, Sh. N. Ibragimov, S. M. Dzhanklich. – Tashkent: IPTD "Uzbekistan", 2021. – 176 с.
Walboomers JM, Jacobs MV, Manos MM. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Jay Patel.1999 г.; 189 : 12–9.
A call for action to eliminate cervical cancer worldwide. Available online: https://www.uicc.org/news/a%C2%A0call-action-eliminate-cervical-cancer-globally
